Ingestible devices that include electronic circuitry have been proposed for use in a variety of different medical applications, including both diagnostic and therapeutic applications.
Examples of such ingestible devices are ingestible electronic capsules which collect data as they pass through the body, and transmit the data to an external receiver system. An example of this type of electronic capsule is disclosed in U.S. Pat. No. 5,604,531 Iddan et al., which describes what is called an in vivo video camera. The swallowable capsule includes a camera system and an optical system for imaging an area of interest onto the camera system. The transmitter transmits the video output of the camera system and the reception system receives the transmitted video output. U.S. Pat. No. 7,009,634 also issued to Iddan et al discloses an ingestible imaging device that obtains images from within body lumens or cavities. The electronic circuit components of the device are enclosed by an inert indigestible housing (e.g. glass housing) that passes through the body internally. U.S. Pat. No. 6,800,060 issued to Marshall discloses an ingestible data recorder capsule medical device. The electronic circuits of the disclosed device (e.g. sensor, recorder, etc.) are housed in a capsule made of inert materials, and therefore ingestible and passable through the digestive tract without being consumed by the body.
In these devices, the electronic circuits are protected in a housing or capsule that prevents damage to the device's electronic circuits during the process of ingestion and elimination in the human body.
Recently, U.S. Patent Application Publication No. 2007/0008113 by Spoonhauer et al. disclosed fragile radio frequency identification (RFID) tags for use in drug ingestion monitoring applications. The RFID tags disclosed in this application are simple antenna structures that are configured to break down during transit through the body.
In certain instances, more complex circuitry suitable for use in ingestible devices is needed.
The present invention provides for robust ingestible circuitry, where the components of the ingestible circuitry are ingestible, and in some instances digestible. As the ingestible circuitry is made up of ingestible, and even digestible, components, the ingestible circuitry results in little, if any, unwanted side effects, even when employed in chronic situations. The ingestible circuitry is particularly suited for use in signal identifiers, e.g., as may be found in ingestible event markers (IEMs), which include pharma-informatics enabled compositions.
Embodiments of ingestible circuitry of the invention include a solid support of an ingestible material, which support has on a surface thereof one or more electronic components. Components that may be present on the surface of the support may vary, and include but are not limited to: logic and/or memory elements, e.g., in the form of an integrated circuit; a power device, e.g., battery, fuel cell or capacitor; an effector, e.g., sensor, stimulator, etc.; a signal transmission element, e.g., in the form of an antenna, electrode, coil, etc.; a passive element, e.g., an inductor, resistor, etc. The one or more components on the surface of the support may be laid out in any convenient configuration. Where two or more components are present on the surface of the solid support, interconnects may be provided. All of the components and the support of the ingestible circuitry are ingestible, and in certain instances digestible.
The present invention provides for ingestible circuitry, where the components of the circuitry are ingestible, and in some instances digestible. As the ingestible circuitry is made up of ingestible, and even digestible, components, the ingestible circuitry results in little, if any, unwanted side effects, even when employed in chronic situations.
Embodiments of ingestible circuitry of the invention include a solid support of an ingestible material, which support has on a surface thereof one or more electronic components. Components that may be present on the surface of the support may vary, and include but are not limited to: logic and/or memory elements, e.g., in the form of an integrated circuit; a power device, e.g., battery, fuel cell or capacitor; an effector, e.g., sensor, stimulator, etc.; a signal transmission element, e.g., in the form of an antenna, electrode, coil, etc.; a passive element, e.g., an inductor, resistor, etc. The one or more components on the surface of the support may be laid out in any convenient configuration. Where two or more components are present on the surface of the solid support, interconnects may be provided.
The ingestible circuitry is particularly suited for use in signal identifiers, e.g., as may be found in ingestible event markers and pharma-informatics enabled compositions. One example includes use of the ingestible circuitry in association with a specific pharmaceutical product, such as a pill, to determine when a patient takes the pharmaceutical product. As the pill is consumed, the ingestible circuit is activated and generates a signal that is detected thereby signifying that the pharmaceutical product has been taken by a patient.
Ingestible Circuitry and Fabrication Thereof
As summarized above, the present invention provides ingestible circuitry. Ingestible circuitry of the invention includes a solid support fabricated from an ingestible material, and one or more electronic components displayed on a surface thereof. Where two or more components are present on a given solid support, conductive interconnecting elements are also present that electrically couple the two or more components. A variety of different types of components may be present on the support, as reviewed in greater detail below. In addition, one or more optional elements, such as a protective layer, etc., may be provided.
Ingestible circuitry of the invention can be a standalone unit or it can be incorporated into another structure, e.g., an ingestible identifier, such as may be found in an ingestible event marker, including a pharma-informatics enabled pharmaceutical composition.
As summarized above, circuitry of the invention is ingestible, where the disparate components of the circuitry are fabricated from ingestible materials. In certain embodiments, one or more of the ingestible materials of the circuits are digestible materials. As such, the amounts of the materials are below chronic ingestion limits if the circuitry is present in a device that is going to be ingested chronically. If the circuitry is incorporated into a device that is going to be ingested less frequently, materials may be chosen based on the anticipated dosage schedule.
As reviewed above, elements of the ingestible circuitry of the invention include a solid support, one or more electronic components, and interconnects, among other elements.
The solid support is the structure on which all of the components are present. The solid support is fabricated from an ingestible material, where the material is a dielectric or insulating material. It can be fabricated from a variety of materials. Materials that provide mechanical strength and may be employed as an insoluble component of the solid support include, but are not limited to: Ethyl cellulose (e.g. Hercules Aqualon or Dow Ethocel), cellulose acetate, Agar, Gelatin. Insoluble materials of interest include ethylcellulose, a copolymer of acrylic acid and methacrylic acid esters, having from about 5 to 10% functional quaternary ammonium groups, polyethylene, polyamide, polyvinylchloride, polyvinyl acetate and any mixtures thereof. Fillers, such as, starch, glucose, lactose, inorganic salts such as sodium or potassium chloride, carbonates, bicarbonates, sulfates, nitrates, silicates (e.g., magnesium silicate) and alkali metals phosphates and oxides (e.g., titanium dioxide, magnesium oxide), may also be present. Soluble materials that may be employed, e.g., as disintegrating agents, in the solid support include, but are not limited to: Hydroxypropyl cellulose, hydroxyethylcellulose, carboxymethylcellulose, croscarmellose, hypromellose, hydroxypropyl methyl cellulose, methyl cellulose, Polysaccharides (starch, different sugars); Polyvinyl alcohol; Gums (guar, xanthan, acacia); Alginates (sodium or calcium alginate); povidone; etc. Also of interest are Plasticizing agents, e.g., Dibutyl sebacate, triacetin, triethyl citrate, polyethylene glycol, polyethylene oxide. Soluble materials of interest include proteins, polysaccharides, polyacrylates, hydrogels, polyvinyl alcohol, polyvinyl pyrrolidone, and derivatives of such polymers. In certain embodiments, plasticizers may be present, where plasticizers make it easier to process and modulate the strength so that it is not stiff and brittle. Also of interest are surfactants. Environmentally sensitive materials may also be present in the support, such as environmentally sensitive polymers, e.g., temperature sensitive polymers, ph sensitive polymers (e.g., Polymethacrylates (e.g. Degussa Eudragit®)), oxygen sensitive polymers, enzyme sensitive polymers (e.g., Starch, Chitosan, etc.), that will make it insoluble in certain physiological locations, such as the stomach, and soluble in other physiological locations, such as the intestine. Embodiments of such supports are supports that retain their shape in the stomach and then fall apart upon entry/transit through the intestine. Also present may be foaming agents, e.g., sodium carbonate, swelling agents, e.g., hydrogel polymers, or cross linking agents, e.g., glutaraldehyde. In certain embodiments, the support is fabricated from a foodstuff which has suitable properties. Foodstuffs of interest include, but are not limited to: soy, whey, wheat glutein, rice starch, tapioca starch, rice paper, nori, corn chips, potato, pasta, filo, fruit roll-ups, haw flakes, crackers, gelatin and gummy. The solid supports can be fabricated via any convenient protocol, such as through deposition via a number of methods such as solvent cast, or melt extrusion.
Also present in ingestible circuitry is one or more conductive elements which serve to interconnect two or more distinct components on a surface(s) of the support. In certain embodiments, this conductive element, e.g., interconnect or wire, is a thin layer or strip of a homogenous conductive and ingestible material, such as gold, silver, graphite, titanium, copper, etc. The material making up the conductive element may be any material whose total amount is below chronic ingestion limits (i.e., how often one is ingesting the ingestible device) where the conductivity is within a desired range. Table 1 below provides examples of ranges.
The conductive elements (i.e., interconnects) can be deposited on a surface of the support to provide interconnection between two or more components as a homogeneous layer, for example a layer of gold. Any convenient deposition protocol may be employed, such as but not limited to: evaporation, plating, electrolysis plating, galvanic deposition, screen or ink jet printing, or other thin layer deposition techniques. Alternatively, a lamination method may be employed, where various elements are positioned as sheets. In yet other embodiments, a decal transfer process may be employed, where each of the distinct elements is on a separate backing layer. The distinct elements are transferred to the solid support, and then the backing layer is removed. With each of the above protocols, a patterning technique may be employed. The choice of patterning technique will depend on the choice of deposition process and the dimensional control required of the final pattern, for example evaporation or plating is very compatible with photo lithography. For laminate protocols, laser patterning might be employed, e.g., where a layer is deposited and the unwanted portions are cut out. In certain embodiments, purely additive techniques, such as ink jet or screen printing, are employed.
Instead of having a conductive element fabricated from a homogenous material, the conductive element can be a heterogenous material that is a paste or an ink. For example, a suspension of a conductive filler of the conductive materials, e.g., gold, silver, graphite, etc., with an ingestible binder material, such as a polymer, a thermoset or thermoplastic polymer, may be employed. This heterogenous material can contain other polymeric components such as plasticizers, surfactants to make the ink and the paste flow better, be more processable etc. In yet other embodiments, the conductive element is an isotropic conductive film, e.g., a film of inert particles, such as of a material like glass, that have been coated with a conductive material, e.g., a metal.
Electrical connection between the conductive element and components on the support may be achieved in a number of different ways. For example, interconnects and various components may be positioned on a surface of the solid support, and a layer of conductive material that covers the disparate components and conductive elements can be deposited in a manner that provides the desired connection. Alternatively, ingestible conductive glues, pastes and adhesives may be employed. In certain embodiments, of interest is the use of a combination of two (or more) glues, where one of the glues provides for desired conductive properties and one of the glues provides mechanical strength. In addition, mechanical attachment protocols such as pressing different components together, e.g., where the components have suitable shape interfaces that make it easier for them to bond under mechanical force, pressure, and temperature, may be employed. Also of interest is laser welding, sonic welding, etc. The components can be immobilized relative to a surface of the solid support by mechanically holding the components on to the solid support, e.g., via deposition of a conductive overlay, as reviewed above, by way of a glue, such as a thermoplastic glue that physically holds items in place or thermosetting glue that is cross linked. Lasers may be employed with mixtures of some metals or conductive elements and locally sintered to make an electrical contact at the sintered point (e.g., where the laser removes or densifies an organic material in a binder, leaving a more thermally stable conductive material behind).
In addition to the above components, the ingestible circuitry of the invention also includes one or more electronic components. Electrical components of interest include, but are not limited to: logic and/or memory elements, e.g., in the form of an integrated circuit; a power device, e.g., battery, fuel cell or capacitor; an effector, e.g., sensor, stimulator, etc.; a signal transmission element, e.g., in the form of an antenna, electrode, coil, etc.; a passive element, e.g., an inductor, resistor, etc.
The various components may be produced on a surface of a solid support using a variety of different protocols. For example, where the components are electrode elements that make up a battery which is activated upon contact with stomach fluid, e.g., as described below, the battery components can be deposited directly onto the solid support. For example, a magnesium layer can be evaporated onto a surface of the solid support, where the solid support is fabricated from a material(s) that withstands the temperature and pressure that occurs during that deposition process. The different components of the electrodes can be deposited onto a conductor layer that is then attached to the solid support. For example, one can have a thin sheet of gold, and a layer of CuCl can be deposited onto the gold, with the resultant product being attached to the solid support. The different layers can also be deposited via an ink or a paste. For example, a structure of CuCl deposited on gold can be broken up into small particles, and an ink material can be fabricated from the particles. The resultant ink material can be used to either print or silk screen the desired electrode pattern onto the solid support. Also of interest are protocols that employ screen printing or ink jet printing techniques. In yet other embodiments, an unpatterned slurry is deposited. In yet other embodiments, “roll-to-roll” or “continuous web” protocols are employed.
In certain embodiments, the ingestible circuitry includes a coating layer. The purpose of this coating layer can vary, e.g., to protect the circuitry, the chip and/or the battery, or any components during processing, during storage, or even during ingestion. For example, one may not desire the circuitry to be exposed to the body fluids after it is ingested. In such instances, it may be desirable to only have the battery and transmit antennas be exposed to body fluids, with the rest of the circuitry being protected. In such instances, a coating on top of the circuitry that is ingestible but does not dissolve until the device is finished doing its transmission may be provided. Also of interest are coatings that are designed to protect the ingestible circuitry during storage, but dissolve immediately during use. For example, coatings that dissolve upon contact with an aqueous fluid, e.g., stomach fluid. Also of interest are protective processing coatings that are employed to allow the use of processing steps that would otherwise damage certain components of the device. For example, in embodiments where a chip with battery material deposited on the top and bottom is produced, the product needs to be diced. However, the dicing process can scratch off the battery material, and also there might be liquid involved which would cause the battery materials to discharge or dissolve. In such instances, a protective coating on the battery that prevents mechanical or liquid contact with the battery component during processing can be employed. Another purpose of the edible coatings would be to control the activation of the device. For example, an edible coating that sits on the battery electrodes and takes a certain period of time, e.g., five minutes, to dissolve upon contact with stomach fluid may be employed. The coating can also be an environmentally sensitive coating, e.g., a temperature or pH sensitive coating, or other chemically sensitive coating that provides for dissolution in a controlled fashion and allows one to activate the device when desired. Coatings that survive the stomach but dissolve in the intestine are also of interest, e.g., where one desires to delay activation until the device leaves the stomach. An example of such a coating is a polymer that is insoluble at low pH, but becomes soluble at a higher pH. Also of interest are pharmaceutical formulation protective coatings, e.g., a gel cap liquid protective coating that prevents the circuit from being activated by liquid of the gel cap.
Another component present in certain embodiments of the ingestible circuit is an activation mechanism, e.g., where the activation mechanism is distinct from the power source (e.g., battery). An example of such an alternative activation element is a patch of circuit that closes upon contact with fluid and activates the device. Another example is the reactive removal of a patch of the circuit that, before it is removed, keeps the circuit from operating.
As indicated above, ingestible circuitry devices in accordance with the invention may be fabricated in a variety of different ways. Any of a variety of different protocols may be employed in manufacturing the circuitry structures and components thereof. For example, molding, deposition and material removal, e.g., planar processing techniques, such as Micro-Electro-Mechanical Systems (MEMS) fabrication techniques, including surface micromachining and bulk micromachining techniques, may be employed. Deposition techniques that may be employed in certain embodiments of fabricating the structures include, but are not limited to: electroplating, cathodic arc deposition, plasma spray, screen or ink jet printing, sputtering, e-beam evaporation, physical vapor deposition, chemical vapor deposition, plasma enhanced chemical vapor deposition, etc. Material removal techniques included, but are not limited to: reactive ion etching, anisotropic chemical etching, isotropic chemical etching, sacrificial lift-off etching, planarization, e.g., via chemical mechanical polishing, laser ablation, electronic discharge machining (EDM), etc. Also of interest are lithographic protocols. Of interest in certain embodiments is the use of planar processing protocols, in which structures are built up and/or removed from a surface or surfaces of an initially planar substrate using a variety of different material removal and deposition protocols applied to the substrate in a sequential manner. Illustrative fabrication methods of interest are described in greater detail in PCT application serial nos. PCT/US2006/016370; PCT/US2007/022257; PCT/US2007/082563; PCT/US2008/052845; PCT/US2008/053999; and PCT/US2008/077753; the disclosures of which are herein incorporated by reference.
In certain embodiments, of interest is a bifurcated laminate process for preparing a device made up of ingestible circuitry. In this bifurcated laminate process, a laminate component is made separate from a circuitry component, allowing greater freedom in terms of processing protocols than may be employed to fabricate the disparate components together, since protocols may be employed to fabricate a first component that cannot be used to fabricate the other, and vice versa. In such bifurcated laminate protocols, the circuitry and laminate components are combined into a single device following separate fabrication of the two components. To combine the two components, any convenient protocol may be employed. In certain embodiments, the circuitry component is fixed into receiving feature of the laminate component, and fixed in place with a suitable adhesive, such as a conductive adhesive. An example of the use of this protocol for the fabrication of an ingestible event marker according to an embodiment of the invention is provided below in connection with a description of
In
Fabricated separate from the laminate component is the circuitry component. The circuitry component may be fabricated using any convenient protocol, e.g., as summarized above.
Next, a hole or passage 720 configured to receive the circuitry component (e.g., integrated circuit (IC)) is punched in the resultant laminate component 722 to receive the circuitry component 724, as shown in
In a variation of the above protocol, a pre-punched lower laminate is employed. In this embodiment, the IC is placed onto a pre-punch hole, where prior to placement, the sheet may be covered with a pressure sensitive adhesive material that is removed prior to chip placement during punching but is removed prior to chip placement. A second laminate is applied over the top of the chips and then opened, e.g., with a laser, over the chips and the top conductor (e.g., battery material) is additively applied, e.g., by screen printing. A final non-conductive layer, such as treated paper or plastic, is used in a roll-to-roll process after this step to isolate the two sides of the battery before the IEMs are finally punched out of the roll for assembly into tablets or capsules.
Finally, a disc shaped device 740, e.g., shown by dashed lines in
The above bifurcated laminate protocol finds use in, among other applications, fabricating IEMs that have a virtual dipole, e.g., as described in greater detail in pending U.S. Provisional Application Ser. No. 60/975,108 titled “Virtual Dipole Signal Amplification For Pharma-Informatics System” and filed on Sep. 25, 2007, the disclosure of which is herein incorporated by reference.
Devices Comprising Ingestible Circuitry
Ingestible circuitry of the invention finds use in a variety of different types of devices. One example of a device that can include ingestible circuitry of the invention is an ingestible identifier. Ingestible identifiers are described in PCT application serial no. PCT/US2006/016370 published as WO/2006/116718; PCT application serial no. PCT/US2007/082563 published as WO/2008/052136; PCT application serial no. PCT/US2007/024225 published as WO/2008/063626; PCT application serial no. PCT/US2007/022257 published as WO/2008/066617; PCT application serial no. PCT/US2008/052845 published as WO/2008/095183; PCT application serial no. PCT/US2008/053999 published as WO/2008/101107; PCT application serial no. PCT/US2008/056296 published as WO/2008/112577; PCT application serial no. PCT/US2008/056299 published as WO/2008/112578; PCT application serial no. PCT/US2008/077753 published as WO2009/042812; PCT application serial no. PCT/US2008/085048 published as WO 2009/070773; and PCT application serial no. PCT/US2009/36231; as well as pending U.S. application Ser. Nos. 12/126,792 and 12/126,798; the disclosures of which are incorporated herein by reference.
An example of such an ingestible identifier is an identifier that includes battery. The battery includes, when completed, a cathode, an anode, and an electrolyte, where the electrolyte component is provided by a physiological fluid, e.g., stomach acid. When the identifier is ingested and reaches the stomach, the cathode and anode are exposed to stomach fluid. The stomach fluid (either by itself or when combined with a dried conductive precursor medium component of the identifier, e.g., as described in pending PCT application serial no: PCT/US2007/082563 the disclosure of which is herein incorporated by reference) acts as the electrolyte component of the battery. Completion of the battery powers the circuitry of the identifier which, in turn broadcasts a detectable signal.
Identifiers of interest include two dissimilar electrochemical materials which constitute the two electrodes (e.g., anode and cathode) of the battery. When the electrode materials are exposed and come into contact with the body fluid, such as stomach acid or other types of fluid (either alone or in combination with a dried conductive medium precursor), a potential difference, that is, a voltage, is generated between the electrodes as a result of the respective oxidation and reduction reactions incurred to the two electrode materials. A voltaic cell, or battery, can thereby be produced. Accordingly, in embodiments of the invention, such batteries are configured such that when the two dissimilar materials are exposed to the target site, e.g., the stomach, the digestive tract, etc., during the physical and chemical erosion of the composition in which the signal generation element is present, a voltage is generated. The two dissimilar materials in an electrolyte are at different potentials. As an example, copper and zinc when put into a cell have different potentials. Similarly, gold and magnesium have different potentials. As a result, a potential difference between the two dissimilar materials is generated.
In certain of these embodiments, the battery power source may be viewed as a power source that exploits electrochemical reaction in an ionic solution such as gastric fluid, blood, or other bodily fluids and some tissues.
Electrodes 12 and 13 can be made of any two materials appropriate to the environment in which the identifier 10 will be operating. The active materials are any pair of materials with different electrochemical potentials, as long as they are ingestible, e.g., as described above. For instance, in some embodiments where ionic solution 16 comprises stomach acids, electrodes 12 and 13 may be made of a noble metal (e.g., gold, silver, platinum, palladium or the like) so that they do not corrode prematurely. Suitable materials are not restricted to metals, and in certain embodiments the paired materials are chosen from metals and non-metals, e.g., a pair made up of a metal (such as Mg) and a salt (such as CuCl or CuI). With respect to the active electrode materials, any pairing of substances—metals, salts, or intercalation compounds—with suitably different electrochemical potentials (voltage) and low interfacial resistance are suitable.
Materials and pairings of interest include, but are not limited to those reported in Table 2 below.
In certain embodiments, one or both of the metals may be doped with a non-metal, e.g., to enhance the voltage output of the battery. Non-metals that may be used as doping agents in certain embodiments include, but are not limited to: sulfur, iodine and the like.
In certain embodiments, the electrode materials are cuprous iodine (CuI) or cuprous chloride as the cathode and magnesium (Mg) metal or magnesium alloy as the anode. Embodiments of the present invention use electrode materials that are not harmful to the human body.
In certain embodiments, the batteries have a small form factor. Batteries may be about 20 mm3 or smaller, e.g., about 10 mm3 or smaller, such as 1.0 mm3 or smaller, including 0.1 mm3 or smaller, including 0.02 mm3 or smaller. In certain embodiments, the battery element is dimensioned to have a width ranging from about 0.01 mm to about 100 mm, e.g., from about 0.1 mm to about 20 mm, including from about 0.5 mm to about 2 mm; a length ranging from about 0.01 mm to about 100 mm, e.g., from about 0.1 mm to about 20 mm, including from about 0.5 mm to about 2 mm, and a height ranging from about 0.01 mm to about 10 mm, e.g., from about 0.05 mm to about 2 mm, including from about 0.1 mm to about 0.5 mm.
The ingestible identifier 10 uses the voltage potential difference to power up electronic circuit 14. In one embodiment, the electronic circuit 14 modulates conductance to create a unique and identifiable current signature.
In certain embodiments, the battery has a laminate structure. As indicated above, a laminate process may be employed to fabricate ingestible circuitry in accordance with the invention. An example of such a laminate process is illustrated in
In
In certain instances, laser patterning may be employed during fabrication of ingestible circuits of the invention, e.g., as illustrated in
Ingestible identifiers that include ingestible circuitry of the invention find use in a variety of different applications. One application of interest is the use of the ingestible identifiers as ingestible event markers (IEMs). Ingestible event markers can be used in both therapeutic and non-therapeutic applications, and are described in PCT application serial no. PCT/US2006/016370 published as WO/2006/116718; PCT application serial no. PCT/US2007/082563 published as WO/2008/052136; PCT application serial no. PCT/US2007/024225 published as WO/2008/063626; PCT application serial no. PCT/US2007/022257 published as WO/2008/066617; PCT application serial no. PCT/US2008/052845 published as WO/2008/095183; PCT application serial no. PCT/US2008/053999 published as WO/2008/101107; PCT application serial no. PCT/US2008/056296 published as WO/2008/112577; PCT application serial no. PCT/US2008/056299 published as WO/2008/112578; PCT application serial no. PCT/US2008/077753 published as WO 2009/042812; PCT application serial no. PCT/US2008/085048 published as WO 2009/070773; and PCT application serial no. PCT/US2009/36231; as well as pending U.S. application Ser. Nos. 12/126,792 and 12/126,798; the disclosures of which are incorporated herein by reference.
The disclosure of these ingestible event markers and applications for the same therein is specifically incorporated herein by reference. Therapeutic applications of ingestible identifiers are embodiments where, at least in some instances, the identifier is associated with a pharmaceutical composition. Medical embodiments of the present invention provide the clinician an important new tool in their therapeutic armamentarium: automatic detection and identification of pharmaceutical agents actually delivered into the body. The applications of this new information device and system are multi-fold. Applications include, but are not limited to: (1) monitoring patient compliance with prescribed therapeutic regimens; (2) tailoring therapeutic regimens based on patient compliance; (3) monitoring patient compliance in clinical trials; (4) monitoring usage of controlled substances; and the like. Each of these different illustrative applications is reviewed in greater detail in PCT application serial no. PCT/US2006/016370 published as WO/2006/116718; PCT application serial no. PCT/US2007/082563 published as WO/2008/052136; PCT application serial no. PCT/US2007/024225 published as WO/2008/063626; PCT application serial no. PCT/US2007/022257 published as WO/2008/066617; PCT application serial no. PCT/US2008/052845 published as WO/2008/095183; PCT application serial no. PCT/US2008/053999 published as WO/2008/101107; PCT application serial no. PCT/US2008/056296 published as WO/2008/112577; PCT application serial no. PCT/US2008/056299 published as WO/2008/112578; PCT application serial no. PCT/US2008/077753 published as WO2009/042812; PCT application serial no. PCT/US2008/085048 published as WO 2009/070773; and PCT application serial no. PCT/US2009/36231; as well as pending U.S. application Ser. Nos. 12/126,792 and 12/126,798; the disclosures of which are incorporated herein by reference.
It is to be understood that this invention is not limited to particular embodiments described, as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges and are also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, representative illustrative methods and materials are now described.
All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference and are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited. The citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
It is noted that, as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. Any recited method can be carried out in the order of events recited or in any other order which is logically possible.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Accordingly, the preceding merely illustrates the principles of the invention. It will be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language recited herein are principally intended to aid the reader in understanding the principles of the invention and the concepts contributed by the inventors to furthering the art, and are to be construed as being without limitation to such specifically recited examples and conditions. Moreover, all statements herein reciting principles, aspects, and embodiments of the invention as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure. The scope of the present invention, therefore, is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of present invention is embodied by the appended claims.
Pursuant to 35 U.S.C. §119 (e), this application claims priority to the filing dates of U.S. Provisional Application Ser. Nos. 61/088,355 filed on Aug. 13, 2008, the disclosures of which are herein incorporated by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2009/053721 | 8/13/2009 | WO | 00 | 7/27/2010 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2010/019778 | 2/18/2010 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3607788 | Adolph | Sep 1971 | A |
3642008 | Bolduc | Feb 1972 | A |
3679480 | Brown et al. | Jul 1972 | A |
3682160 | Murata | Aug 1972 | A |
3719183 | Schwartz | Mar 1973 | A |
3799802 | Mc Cormack et al. | Mar 1974 | A |
3828766 | Krasnow | Aug 1974 | A |
3837339 | Aisenberg et al. | Sep 1974 | A |
3893111 | Cotter | Jul 1975 | A |
3967202 | Batz | Jun 1976 | A |
3989050 | Buchalter | Nov 1976 | A |
4017856 | Wiegand | Apr 1977 | A |
4055178 | Harrigan | Oct 1977 | A |
4077397 | Ellis | Mar 1978 | A |
4077398 | Ellis | Mar 1978 | A |
4082087 | Howson | Apr 1978 | A |
4090752 | Long | May 1978 | A |
4106348 | Auphan | Aug 1978 | A |
4129125 | Lester | Dec 1978 | A |
4166453 | McClelland | Sep 1979 | A |
4239046 | Ong | Dec 1980 | A |
4251795 | Shibasaki et al. | Feb 1981 | A |
4269189 | Abraham | May 1981 | A |
4331654 | Morris | May 1982 | A |
4345588 | Widder et al. | Aug 1982 | A |
4418697 | Tama | Dec 1983 | A |
4425117 | Hugemann et al. | Jan 1984 | A |
4494950 | Fischell | Jan 1985 | A |
4559950 | Vaughan | Dec 1985 | A |
4635641 | Hoffman | Jan 1987 | A |
4654165 | Eisenberg | Mar 1987 | A |
4663250 | Ong et al. | May 1987 | A |
4669479 | Dunseath | Jun 1987 | A |
4725997 | Urquhart et al. | Feb 1988 | A |
4763659 | Dunseath | Aug 1988 | A |
4784162 | Ricks | Nov 1988 | A |
4793825 | Benjamin et al. | Dec 1988 | A |
4844076 | Lesho | Jul 1989 | A |
4896261 | Nolan | Jan 1990 | A |
4975230 | Pinkhasov | Dec 1990 | A |
4987897 | Funke | Jan 1991 | A |
5016634 | Vock et al. | May 1991 | A |
5079006 | Urquhart | Jan 1992 | A |
5167626 | Casper | Dec 1992 | A |
5176626 | Soehendra | Jan 1993 | A |
5261402 | DiSabito | Nov 1993 | A |
5263481 | Axelgaard et al. | Nov 1993 | A |
5279607 | Schentag et al. | Jan 1994 | A |
5281287 | Lloyd | Jan 1994 | A |
5283136 | Peled et al. | Feb 1994 | A |
5305745 | Zacouto | Apr 1994 | A |
5318557 | Gross | Jun 1994 | A |
5394882 | Mawhinney | Mar 1995 | A |
5395366 | D'Andrea et al. | Mar 1995 | A |
5436091 | Shackle et al. | Jul 1995 | A |
5458141 | Neil et al. | Oct 1995 | A |
5485841 | Watkin et al. | Jan 1996 | A |
5596302 | Mastrocola et al. | Jan 1997 | A |
5600548 | Nguyen et al. | Feb 1997 | A |
5634468 | Platt | Jun 1997 | A |
5645063 | Straka et al. | Jul 1997 | A |
5738708 | Peachey et al. | Apr 1998 | A |
5740811 | Hedberg | Apr 1998 | A |
5757326 | Koyama et al. | May 1998 | A |
5792048 | Schaefer | Aug 1998 | A |
5796038 | Manteghi | Aug 1998 | A |
5802467 | Salazar | Sep 1998 | A |
5833716 | Bar-Or | Nov 1998 | A |
5845265 | Woolston | Dec 1998 | A |
5862803 | Besson | Jan 1999 | A |
5868136 | Fox | Feb 1999 | A |
5925030 | Gross et al. | Jul 1999 | A |
5957854 | Besson | Sep 1999 | A |
5963132 | Yoakum et al. | Oct 1999 | A |
5974124 | Schlueter, Jr. et al. | Oct 1999 | A |
5999846 | Pardey et al. | Dec 1999 | A |
6038464 | Axelgaard et al. | Mar 2000 | A |
6042710 | Dubrow | Mar 2000 | A |
6047203 | Sackner | Apr 2000 | A |
6076016 | Feierbach et al. | Jun 2000 | A |
6081734 | Batz | Jun 2000 | A |
6095985 | Raymond et al. | Aug 2000 | A |
6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
6141592 | Pauly | Oct 2000 | A |
6156343 | Morita et al. | Dec 2000 | A |
6200265 | Walsh et al. | Mar 2001 | B1 |
6206702 | Hayden et al. | Mar 2001 | B1 |
6217744 | Crosby | Apr 2001 | B1 |
6231593 | Meserol | May 2001 | B1 |
6245057 | Sieben et al. | Jun 2001 | B1 |
6269058 | Yamanoi et al. | Jul 2001 | B1 |
6285897 | Kilcoyne et al. | Sep 2001 | B1 |
6287252 | Lugo | Sep 2001 | B1 |
6288629 | Cofino et al. | Sep 2001 | B1 |
6289238 | Besson | Sep 2001 | B1 |
6315719 | Rode et al. | Nov 2001 | B1 |
6358202 | Arent | Mar 2002 | B1 |
6364834 | Reuss | Apr 2002 | B1 |
6366206 | Ishikawa et al. | Apr 2002 | B1 |
6371927 | Brune | Apr 2002 | B1 |
6374670 | Spelman | Apr 2002 | B1 |
6380858 | Yarin et al. | Apr 2002 | B1 |
6394997 | Lemelson | May 2002 | B1 |
6426863 | Munshi | Jul 2002 | B1 |
6432292 | Pinto et al. | Aug 2002 | B1 |
6440069 | Raymond et al. | Aug 2002 | B1 |
6441747 | Khair | Aug 2002 | B1 |
6453199 | Kobozev | Sep 2002 | B1 |
6477424 | Thompson et al. | Nov 2002 | B1 |
6496705 | Ng et al. | Dec 2002 | B1 |
6526315 | Inagawa | Feb 2003 | B1 |
6531026 | Takeichi et al. | Mar 2003 | B1 |
6544174 | West | Apr 2003 | B2 |
6564079 | Cory | May 2003 | B1 |
6577893 | Besson | Jun 2003 | B1 |
6579231 | Phipps | Jun 2003 | B1 |
6609018 | Cory | Aug 2003 | B2 |
6612984 | Kerr | Sep 2003 | B1 |
6632175 | Marshall | Oct 2003 | B1 |
6632216 | Houzego et al. | Oct 2003 | B2 |
6643541 | Mok et al. | Nov 2003 | B2 |
6654638 | Sweeney | Nov 2003 | B1 |
6663846 | McCombs | Dec 2003 | B1 |
6673474 | Yamamoto | Jan 2004 | B2 |
6680923 | Leon | Jan 2004 | B1 |
6689117 | Sweeney et al. | Feb 2004 | B2 |
6694161 | Mehrotra | Feb 2004 | B2 |
6704602 | Berg et al. | Mar 2004 | B2 |
6720923 | Hayward et al. | Apr 2004 | B1 |
6738671 | Christophersom et al. | May 2004 | B2 |
6740033 | Olejniczak et al. | May 2004 | B1 |
6745082 | Axelgaard et al. | Jun 2004 | B2 |
6755783 | Cosentino | Jun 2004 | B2 |
6757523 | Fry | Jun 2004 | B2 |
6800060 | Marshall | Oct 2004 | B2 |
6801137 | Eggers et al. | Oct 2004 | B2 |
6822554 | Vrijens et al. | Nov 2004 | B2 |
6836862 | Erekson et al. | Dec 2004 | B1 |
6839659 | Tarassenko et al. | Jan 2005 | B2 |
6840904 | Goldberg | Jan 2005 | B2 |
6842636 | Perrault | Jan 2005 | B2 |
6845272 | Thomsen | Jan 2005 | B1 |
6864780 | Doi | Mar 2005 | B2 |
6879810 | Bouet | Apr 2005 | B2 |
6909878 | Haller | Jun 2005 | B2 |
6922592 | Thompson et al. | Jul 2005 | B2 |
6928370 | Anuzis et al. | Aug 2005 | B2 |
6929636 | von Alten | Aug 2005 | B1 |
6937150 | Medema | Aug 2005 | B2 |
6942616 | Kerr | Sep 2005 | B2 |
6951536 | Yokoi | Oct 2005 | B2 |
6957107 | Rogers et al. | Oct 2005 | B2 |
6968153 | Heinonen | Nov 2005 | B1 |
6977511 | Patel et al. | Dec 2005 | B2 |
6987965 | Ng et al. | Jan 2006 | B2 |
6990082 | Zehavi et al. | Jan 2006 | B1 |
7002476 | Rapchak | Feb 2006 | B2 |
7004395 | Koenck | Feb 2006 | B2 |
7009634 | Iddan et al. | Mar 2006 | B2 |
7009946 | Kardach | Mar 2006 | B1 |
7013162 | Gorsuch | Mar 2006 | B2 |
7016648 | Haller | Mar 2006 | B2 |
7020508 | Stivoric | Mar 2006 | B2 |
7024248 | Penner et al. | Apr 2006 | B2 |
7031745 | Shen | Apr 2006 | B2 |
7031857 | Tarassenko et al. | Apr 2006 | B2 |
7039453 | Mullick | May 2006 | B2 |
7046649 | Awater et al. | May 2006 | B2 |
7118531 | Krill | Oct 2006 | B2 |
7127300 | Mazar et al. | Oct 2006 | B2 |
7146228 | Nielsen | Dec 2006 | B2 |
7146449 | Do et al. | Dec 2006 | B2 |
7149581 | Goedeke et al. | Dec 2006 | B2 |
7154071 | Sattler et al. | Dec 2006 | B2 |
7155232 | Godfrey et al. | Dec 2006 | B2 |
7160258 | Imran | Jan 2007 | B2 |
7164942 | Avrahami | Jan 2007 | B2 |
7171166 | Ng et al. | Jan 2007 | B2 |
7171177 | Park et al. | Jan 2007 | B2 |
7171259 | Rytky | Jan 2007 | B2 |
7176784 | Gilbert et al. | Feb 2007 | B2 |
7187960 | Abreu | Mar 2007 | B2 |
7188767 | Penuela | Mar 2007 | B2 |
7194038 | Inkinen | Mar 2007 | B1 |
7206630 | Tarler | Apr 2007 | B1 |
7209790 | Thompson et al. | Apr 2007 | B2 |
7215660 | Perlman | May 2007 | B2 |
7215991 | Besson | May 2007 | B2 |
7218967 | Bergelson | May 2007 | B2 |
7231451 | Law | Jun 2007 | B2 |
7243118 | Lou | Jul 2007 | B2 |
7246521 | Kim | Jul 2007 | B2 |
7249212 | Do | Jul 2007 | B2 |
7252792 | Perrault | Aug 2007 | B2 |
7253716 | Lovoi et al. | Aug 2007 | B2 |
7261690 | Teller | Aug 2007 | B2 |
7270633 | Goscha | Sep 2007 | B1 |
7273454 | Raymond et al. | Sep 2007 | B2 |
7289855 | Nghiem | Oct 2007 | B2 |
7291497 | Holmes | Nov 2007 | B2 |
7292139 | Mazar et al. | Nov 2007 | B2 |
7294105 | Islam | Nov 2007 | B1 |
7313163 | Liu | Dec 2007 | B2 |
7317378 | Jarvis et al. | Jan 2008 | B2 |
7318808 | Tarassenko et al. | Jan 2008 | B2 |
7336929 | Yasuda | Feb 2008 | B2 |
7342895 | Serpa | Mar 2008 | B2 |
7346380 | Axelgaard et al. | Mar 2008 | B2 |
7349722 | Witkowski et al. | Mar 2008 | B2 |
7352998 | Palin | Apr 2008 | B2 |
7353258 | Washburn | Apr 2008 | B2 |
7357891 | Yang et al. | Apr 2008 | B2 |
7359674 | Markki | Apr 2008 | B2 |
7366558 | Virtanen et al. | Apr 2008 | B2 |
7368191 | Andelman et al. | May 2008 | B2 |
7373196 | Ryu et al. | May 2008 | B2 |
7375739 | Robbins | May 2008 | B2 |
7376435 | McGowan | May 2008 | B2 |
7382263 | Danowski et al. | Jun 2008 | B2 |
7387607 | Holt | Jun 2008 | B2 |
7388903 | Godfrey et al. | Jun 2008 | B2 |
7389088 | Kim | Jun 2008 | B2 |
7392015 | Farlow | Jun 2008 | B1 |
7395106 | Ryu et al. | Jul 2008 | B2 |
7396330 | Banet | Jul 2008 | B2 |
7404968 | Abrams et al. | Jul 2008 | B2 |
7413544 | Kerr | Aug 2008 | B2 |
7414534 | Kroll et al. | Aug 2008 | B1 |
7414543 | Rye et al. | Aug 2008 | B2 |
7415242 | Ngan | Aug 2008 | B1 |
7424268 | Diener | Sep 2008 | B2 |
7424319 | Muehlsteff | Sep 2008 | B2 |
7427266 | Ayer et al. | Sep 2008 | B2 |
7471665 | Perlman | Dec 2008 | B2 |
7499674 | Salokannel | Mar 2009 | B2 |
7510121 | Koenck | Mar 2009 | B2 |
7512448 | Malick | Mar 2009 | B2 |
7515043 | Welch | Apr 2009 | B2 |
7519416 | Sula et al. | Apr 2009 | B2 |
7523756 | Minai | Apr 2009 | B2 |
7525426 | Edelstein | Apr 2009 | B2 |
7539533 | Tran | May 2009 | B2 |
7542878 | Nanikashvili | Jun 2009 | B2 |
7551590 | Haller | Jun 2009 | B2 |
7554452 | Cole | Jun 2009 | B2 |
7575005 | Mumford | Aug 2009 | B2 |
7616111 | Covannon | Nov 2009 | B2 |
7617001 | Penner et al. | Nov 2009 | B2 |
7639473 | Hsu et al. | Dec 2009 | B2 |
7640802 | King et al. | Jan 2010 | B2 |
7647112 | Tracey | Jan 2010 | B2 |
7647185 | Tarassenko et al. | Jan 2010 | B2 |
7653031 | Godfrey et al. | Jan 2010 | B2 |
7672714 | Kuo | Mar 2010 | B2 |
7673679 | Harrison et al. | Mar 2010 | B2 |
7678043 | Gilad | Mar 2010 | B2 |
7697994 | VanDanacker et al. | Apr 2010 | B2 |
7720036 | Sadri | May 2010 | B2 |
7729776 | Von Arx et al. | Jun 2010 | B2 |
7733224 | Tran | Jun 2010 | B2 |
7736318 | Costentino | Jun 2010 | B2 |
7756587 | Penner et al. | Jul 2010 | B2 |
7796043 | Euliano et al. | Sep 2010 | B2 |
7809399 | Lu | Oct 2010 | B2 |
7844341 | Von Arx et al. | Nov 2010 | B2 |
20010027331 | Thompson | Oct 2001 | A1 |
20010044588 | Mault | Nov 2001 | A1 |
20010051766 | Gazdzinski et al. | Dec 2001 | A1 |
20020002326 | Causey, III | Jan 2002 | A1 |
20020026111 | Ackerman | Feb 2002 | A1 |
20020032385 | Raymond et al. | Mar 2002 | A1 |
20020040278 | Anuzis et al. | Apr 2002 | A1 |
20020077620 | Sweeney et al. | Jun 2002 | A1 |
20020132226 | Nair | Sep 2002 | A1 |
20020193669 | Glukhovsky | Dec 2002 | A1 |
20030017826 | Fishman | Jan 2003 | A1 |
20030023150 | Yokoi et al. | Jan 2003 | A1 |
20030028226 | Thompson | Feb 2003 | A1 |
20030062551 | Chen | Apr 2003 | A1 |
20030065536 | Hansen | Apr 2003 | A1 |
20030076179 | Branch et al. | Apr 2003 | A1 |
20030083559 | Thompson | May 2003 | A1 |
20030126593 | Mault | Jul 2003 | A1 |
20030130714 | Nielsen et al. | Jul 2003 | A1 |
20030135128 | Suffin et al. | Jul 2003 | A1 |
20030135392 | Vrijens et al. | Jul 2003 | A1 |
20030152622 | Louie-Helm et al. | Aug 2003 | A1 |
20030158466 | Lynn et al. | Aug 2003 | A1 |
20030158756 | Abramson | Aug 2003 | A1 |
20030162556 | Libes | Aug 2003 | A1 |
20030167000 | Mullick et al. | Sep 2003 | A1 |
20030171791 | KenKnight | Sep 2003 | A1 |
20030171898 | Tarassenko et al. | Sep 2003 | A1 |
20030181788 | Yokoi et al. | Sep 2003 | A1 |
20030185286 | Yuen | Oct 2003 | A1 |
20030187337 | Tarassenko et al. | Oct 2003 | A1 |
20030187338 | Say et al. | Oct 2003 | A1 |
20030195403 | Berner et al. | Oct 2003 | A1 |
20030213495 | Fujita et al. | Nov 2003 | A1 |
20030214579 | Iddan | Nov 2003 | A1 |
20030216622 | Meron et al. | Nov 2003 | A1 |
20030216625 | Phipps | Nov 2003 | A1 |
20030216666 | Ericson et al. | Nov 2003 | A1 |
20030216729 | Marchitto | Nov 2003 | A1 |
20040008123 | Carrender et al. | Jan 2004 | A1 |
20040018476 | LaDue | Jan 2004 | A1 |
20040034295 | Salganicoff | Feb 2004 | A1 |
20040049245 | Gass | Mar 2004 | A1 |
20040073095 | Causey et al. | Apr 2004 | A1 |
20040073454 | Urquhart et al. | Apr 2004 | A1 |
20040077995 | Ferek-Petric | Apr 2004 | A1 |
20040082982 | Gord et al. | Apr 2004 | A1 |
20040087839 | Raymond et al. | May 2004 | A1 |
20040092801 | Drakulic | May 2004 | A1 |
20040106859 | Say et al. | Jun 2004 | A1 |
20040115517 | Fukuda et al. | Jun 2004 | A1 |
20040121015 | Chidlaw et al. | Jun 2004 | A1 |
20040148140 | Tarassenko et al. | Jul 2004 | A1 |
20040153007 | Harris | Aug 2004 | A1 |
20040167226 | Serafini | Aug 2004 | A1 |
20040167801 | Say et al. | Aug 2004 | A1 |
20040193020 | Chiba | Sep 2004 | A1 |
20040193446 | Mayer et al. | Sep 2004 | A1 |
20040199222 | Sun et al. | Oct 2004 | A1 |
20040215084 | Shimizu et al. | Oct 2004 | A1 |
20040218683 | Batra | Nov 2004 | A1 |
20040220643 | Schmidt | Nov 2004 | A1 |
20040224644 | Wu | Nov 2004 | A1 |
20040225199 | Evanyk | Nov 2004 | A1 |
20040253304 | Gross et al. | Dec 2004 | A1 |
20040260154 | Sidelnik | Dec 2004 | A1 |
20050017841 | Doi | Jan 2005 | A1 |
20050020887 | Goldberg | Jan 2005 | A1 |
20050021370 | Riff | Jan 2005 | A1 |
20050024198 | Ward | Feb 2005 | A1 |
20050027205 | Tarassenko et al. | Feb 2005 | A1 |
20050038321 | Fujita et al. | Feb 2005 | A1 |
20050043634 | Yokoi et al. | Feb 2005 | A1 |
20050062644 | Leci | Mar 2005 | A1 |
20050065407 | Nakamura et al. | Mar 2005 | A1 |
20050070778 | Lackey | Mar 2005 | A1 |
20050092108 | Andermo | May 2005 | A1 |
20050096514 | Starkebaum | May 2005 | A1 |
20050096562 | Delalic et al. | May 2005 | A1 |
20050101843 | Quinn | May 2005 | A1 |
20050101872 | Sattler | May 2005 | A1 |
20050115561 | Stahmann et al. | Jun 2005 | A1 |
20050116820 | Goldreich | Jun 2005 | A1 |
20050117389 | Worledge | Jun 2005 | A1 |
20050121322 | Say et al. | Jun 2005 | A1 |
20050131281 | Ayer et al. | Jun 2005 | A1 |
20050143623 | Kojima | Jun 2005 | A1 |
20050148883 | Boesen | Jul 2005 | A1 |
20050154428 | Bruinsma | Jul 2005 | A1 |
20050165323 | Montgomery | Jul 2005 | A1 |
20050177069 | Takizawa | Aug 2005 | A1 |
20050182389 | LaPorte | Aug 2005 | A1 |
20050187789 | Hatlestad et al. | Aug 2005 | A1 |
20050192489 | Marshall | Sep 2005 | A1 |
20050197680 | DelMain et al. | Sep 2005 | A1 |
20050208251 | Aisenbrey | Sep 2005 | A1 |
20050228268 | Cole | Oct 2005 | A1 |
20050234307 | Heinonen | Oct 2005 | A1 |
20050240305 | Bogash et al. | Oct 2005 | A1 |
20050245794 | Dinsmoor | Nov 2005 | A1 |
20050259768 | Yang et al. | Nov 2005 | A1 |
20050261559 | Mumford | Nov 2005 | A1 |
20050267556 | Shuros et al. | Dec 2005 | A1 |
20050277912 | John | Dec 2005 | A1 |
20050277999 | Strother et al. | Dec 2005 | A1 |
20050285746 | Sengupta | Dec 2005 | A1 |
20050288594 | Lewkowicz et al. | Dec 2005 | A1 |
20060001496 | Abrosimov et al. | Jan 2006 | A1 |
20060028727 | Moon et al. | Feb 2006 | A1 |
20060036134 | Tarassenko et al. | Feb 2006 | A1 |
20060061472 | Lovoi et al. | Mar 2006 | A1 |
20060065713 | Kingery | Mar 2006 | A1 |
20060068006 | Begleiter | Mar 2006 | A1 |
20060074283 | Henderson | Apr 2006 | A1 |
20060078765 | Yang et al. | Apr 2006 | A1 |
20060095091 | Drew | May 2006 | A1 |
20060095093 | Bettesh et al. | May 2006 | A1 |
20060100533 | Han | May 2006 | A1 |
20060109058 | Keating | May 2006 | A1 |
20060110962 | Powell | May 2006 | A1 |
20060122667 | Chavan et al. | Jun 2006 | A1 |
20060136266 | Tarassenko et al. | Jun 2006 | A1 |
20060142648 | Banet | Jun 2006 | A1 |
20060145876 | Kimura | Jul 2006 | A1 |
20060148254 | McLean | Jul 2006 | A1 |
20060149339 | Burnes | Jul 2006 | A1 |
20060155174 | Glukhovsky et al. | Jul 2006 | A1 |
20060155183 | Kroecker | Jul 2006 | A1 |
20060161225 | Sormann et al. | Jul 2006 | A1 |
20060179949 | Kim | Aug 2006 | A1 |
20060183993 | Horn | Aug 2006 | A1 |
20060184092 | Atanasoska et al. | Aug 2006 | A1 |
20060204738 | Dubrow et al. | Sep 2006 | A1 |
20060210626 | Spaeder | Sep 2006 | A1 |
20060216603 | Choi | Sep 2006 | A1 |
20060218011 | Walker | Sep 2006 | A1 |
20060235489 | Drew | Oct 2006 | A1 |
20060247505 | Siddiqui | Nov 2006 | A1 |
20060253005 | Drinan | Nov 2006 | A1 |
20060270346 | Ibrahim | Nov 2006 | A1 |
20060273882 | Posamentier | Dec 2006 | A1 |
20060280227 | Pinkney | Dec 2006 | A1 |
20060282001 | Noel | Dec 2006 | A1 |
20060289640 | Mercure et al. | Dec 2006 | A1 |
20060293607 | Alt | Dec 2006 | A1 |
20070002038 | Suzuki | Jan 2007 | A1 |
20070006636 | King et al. | Jan 2007 | A1 |
20070008113 | Spoonhower et al. | Jan 2007 | A1 |
20070016089 | Fischell et al. | Jan 2007 | A1 |
20070027386 | Such | Feb 2007 | A1 |
20070027388 | Chou | Feb 2007 | A1 |
20070038054 | Zhou | Feb 2007 | A1 |
20070049339 | Barak et al. | Mar 2007 | A1 |
20070055098 | Shimizu et al. | Mar 2007 | A1 |
20070060797 | Ball | Mar 2007 | A1 |
20070073353 | Rooney et al. | Mar 2007 | A1 |
20070096765 | Kagan | May 2007 | A1 |
20070106346 | Bergelson | May 2007 | A1 |
20070123772 | Euliano | May 2007 | A1 |
20070129622 | Bourget | Jun 2007 | A1 |
20070130287 | Kumar | Jun 2007 | A1 |
20070135803 | Belson | Jun 2007 | A1 |
20070142721 | Berner et al. | Jun 2007 | A1 |
20070156016 | Betesh | Jul 2007 | A1 |
20070162089 | Mosesov | Jul 2007 | A1 |
20070162090 | Penner | Jul 2007 | A1 |
20070167495 | Brown et al. | Jul 2007 | A1 |
20070167848 | Kuo et al. | Jul 2007 | A1 |
20070173701 | Al-Ali | Jul 2007 | A1 |
20070179347 | Tarassenko et al. | Aug 2007 | A1 |
20070185393 | Zhou | Aug 2007 | A1 |
20070191002 | Ge | Aug 2007 | A1 |
20070196456 | Stevens | Aug 2007 | A1 |
20070207793 | Myer | Sep 2007 | A1 |
20070208233 | Kovacs | Sep 2007 | A1 |
20070213659 | Trovato et al. | Sep 2007 | A1 |
20070237719 | Jones | Oct 2007 | A1 |
20070244370 | Kuo et al. | Oct 2007 | A1 |
20070255198 | Leong et al. | Nov 2007 | A1 |
20070255330 | Lee | Nov 2007 | A1 |
20070270672 | Hayter | Nov 2007 | A1 |
20070279217 | Venkatraman | Dec 2007 | A1 |
20070282174 | Sabatino | Dec 2007 | A1 |
20070282177 | Pilz | Dec 2007 | A1 |
20070299480 | Hill | Dec 2007 | A1 |
20080014866 | Lipowski | Jan 2008 | A1 |
20080020037 | Robertson | Jan 2008 | A1 |
20080021519 | DeGeest | Jan 2008 | A1 |
20080021521 | Shah | Jan 2008 | A1 |
20080027679 | Shklarski | Jan 2008 | A1 |
20080033273 | Zhou | Feb 2008 | A1 |
20080039700 | Drinan et al. | Feb 2008 | A1 |
20080046038 | Hill | Feb 2008 | A1 |
20080051667 | Goldreich | Feb 2008 | A1 |
20080058614 | Banet | Mar 2008 | A1 |
20080062856 | Feher | Mar 2008 | A1 |
20080065168 | Bitton et al. | Mar 2008 | A1 |
20080074307 | Boric-Lubecke | Mar 2008 | A1 |
20080077015 | Boric-Lubecke | Mar 2008 | A1 |
20080077028 | Schaldach et al. | Mar 2008 | A1 |
20080077188 | Denker et al. | Mar 2008 | A1 |
20080091089 | Guillory et al. | Apr 2008 | A1 |
20080091114 | Min | Apr 2008 | A1 |
20080097549 | Colbaugh | Apr 2008 | A1 |
20080097917 | Dicks | Apr 2008 | A1 |
20080103440 | Ferren et al. | May 2008 | A1 |
20080114224 | Bandy et al. | May 2008 | A1 |
20080119705 | Patel | May 2008 | A1 |
20080119716 | Boric-Lubecke | May 2008 | A1 |
20080121825 | Trovato et al. | May 2008 | A1 |
20080137566 | Marholev | Jun 2008 | A1 |
20080140403 | Hughes et al. | Jun 2008 | A1 |
20080146871 | Arneson et al. | Jun 2008 | A1 |
20080146889 | Young | Jun 2008 | A1 |
20080146892 | LeBeouf | Jun 2008 | A1 |
20080154104 | Lamego | Jun 2008 | A1 |
20080166992 | Ricordi | Jul 2008 | A1 |
20080175898 | Jones et al. | Jul 2008 | A1 |
20080183245 | Van Oort | Jul 2008 | A1 |
20080188837 | Belsky et al. | Aug 2008 | A1 |
20080194912 | Trovato et al. | Aug 2008 | A1 |
20080208009 | Shklarski | Aug 2008 | A1 |
20080214901 | Gehman | Sep 2008 | A1 |
20080214985 | Yanaki | Sep 2008 | A1 |
20080243020 | Chou | Oct 2008 | A1 |
20080249360 | Li | Oct 2008 | A1 |
20080262320 | Schaefer et al. | Oct 2008 | A1 |
20080262336 | Ryu | Oct 2008 | A1 |
20080269664 | Trovato et al. | Oct 2008 | A1 |
20080275312 | Mosesov | Nov 2008 | A1 |
20080284599 | Zdeblick et al. | Nov 2008 | A1 |
20080288027 | Kroll | Nov 2008 | A1 |
20080294020 | Sapounas | Nov 2008 | A1 |
20080300572 | Rankers | Dec 2008 | A1 |
20080303638 | Nguyen | Dec 2008 | A1 |
20080306357 | Korman | Dec 2008 | A1 |
20080306359 | Zdeblick et al. | Dec 2008 | A1 |
20080306360 | Robertson | Dec 2008 | A1 |
20080311852 | Hansen | Dec 2008 | A1 |
20080312522 | Rowlandson | Dec 2008 | A1 |
20080316020 | Robertson | Dec 2008 | A1 |
20090009330 | Sakama et al. | Jan 2009 | A1 |
20090009332 | Nunez et al. | Jan 2009 | A1 |
20090024045 | Prakash | Jan 2009 | A1 |
20090030293 | Cooper et al. | Jan 2009 | A1 |
20090030297 | Miller | Jan 2009 | A1 |
20090034209 | Joo | Feb 2009 | A1 |
20090043171 | Rule | Feb 2009 | A1 |
20090048498 | Riskey | Feb 2009 | A1 |
20090062634 | Say et al. | Mar 2009 | A1 |
20090062670 | Sterling | Mar 2009 | A1 |
20090069642 | Gao | Mar 2009 | A1 |
20090069655 | Say et al. | Mar 2009 | A1 |
20090069656 | Say et al. | Mar 2009 | A1 |
20090069657 | Say et al. | Mar 2009 | A1 |
20090069658 | Say et al. | Mar 2009 | A1 |
20090076343 | James | Mar 2009 | A1 |
20090082645 | Hafezi | Mar 2009 | A1 |
20090087483 | Sison | Apr 2009 | A1 |
20090088618 | Ameson | Apr 2009 | A1 |
20090099435 | Say et al. | Apr 2009 | A1 |
20090105561 | Boydon et al. | Apr 2009 | A1 |
20090110148 | Zhang | Apr 2009 | A1 |
20090112626 | Talbot | Apr 2009 | A1 |
20090124871 | Arshak | May 2009 | A1 |
20090131774 | Sweitzer | May 2009 | A1 |
20090135886 | Robertson et al. | May 2009 | A1 |
20090157113 | Marcotte | Jun 2009 | A1 |
20090157358 | Kim | Jun 2009 | A1 |
20090161602 | Matsumoto | Jun 2009 | A1 |
20090163789 | Say et al. | Jun 2009 | A1 |
20090171180 | Pering | Jul 2009 | A1 |
20090173628 | Say et al. | Jul 2009 | A1 |
20090177055 | Say et al. | Jul 2009 | A1 |
20090177056 | Say et al. | Jul 2009 | A1 |
20090177057 | Say et al. | Jul 2009 | A1 |
20090177058 | Say et al. | Jul 2009 | A1 |
20090177059 | Say et al. | Jul 2009 | A1 |
20090177060 | Say et al. | Jul 2009 | A1 |
20090177061 | Say et al. | Jul 2009 | A1 |
20090177062 | Say et al. | Jul 2009 | A1 |
20090177063 | Say et al. | Jul 2009 | A1 |
20090177064 | Say et al. | Jul 2009 | A1 |
20090177065 | Say et al. | Jul 2009 | A1 |
20090177066 | Say et al. | Jul 2009 | A1 |
20090182206 | Najafi | Jul 2009 | A1 |
20090182212 | Say et al. | Jul 2009 | A1 |
20090182213 | Say et al. | Jul 2009 | A1 |
20090182214 | Say et al. | Jul 2009 | A1 |
20090182215 | Say et al. | Jul 2009 | A1 |
20090182388 | Von Arx | Jul 2009 | A1 |
20090187088 | Say et al. | Jul 2009 | A1 |
20090187089 | Say et al. | Jul 2009 | A1 |
20090187090 | Say et al. | Jul 2009 | A1 |
20090187091 | Say et al. | Jul 2009 | A1 |
20090187092 | Say et al. | Jul 2009 | A1 |
20090187093 | Say et al. | Jul 2009 | A1 |
20090187094 | Say et al. | Jul 2009 | A1 |
20090187095 | Say et al. | Jul 2009 | A1 |
20090187381 | King et al. | Jul 2009 | A1 |
20090192351 | Nishino | Jul 2009 | A1 |
20090192368 | Say et al. | Jul 2009 | A1 |
20090192369 | Say et al. | Jul 2009 | A1 |
20090192370 | Say et al. | Jul 2009 | A1 |
20090192371 | Say et al. | Jul 2009 | A1 |
20090192372 | Say et al. | Jul 2009 | A1 |
20090192373 | Say et al. | Jul 2009 | A1 |
20090192374 | Say et al. | Jul 2009 | A1 |
20090192375 | Say et al. | Jul 2009 | A1 |
20090192376 | Say et al. | Jul 2009 | A1 |
20090192377 | Say et al. | Jul 2009 | A1 |
20090192378 | Say et al. | Jul 2009 | A1 |
20090192379 | Say et al. | Jul 2009 | A1 |
20090198115 | Say et al. | Aug 2009 | A1 |
20090198116 | Say et al. | Aug 2009 | A1 |
20090198175 | Say et al. | Aug 2009 | A1 |
20090203964 | Shimizu et al. | Aug 2009 | A1 |
20090203971 | Sciarappa | Aug 2009 | A1 |
20090203972 | Heneghan | Aug 2009 | A1 |
20090203978 | Say et al. | Aug 2009 | A1 |
20090204265 | Hackett | Aug 2009 | A1 |
20090210164 | Say et al. | Aug 2009 | A1 |
20090216101 | Say et al. | Aug 2009 | A1 |
20090216102 | Say et al. | Aug 2009 | A1 |
20090227204 | Robertson et al. | Sep 2009 | A1 |
20090227876 | Tran | Sep 2009 | A1 |
20090227940 | Say et al. | Sep 2009 | A1 |
20090227941 | Say et al. | Sep 2009 | A1 |
20090228214 | Say et al. | Sep 2009 | A1 |
20090231125 | Baldus | Sep 2009 | A1 |
20090234200 | Husheer | Sep 2009 | A1 |
20090243833 | Huang | Oct 2009 | A1 |
20090253960 | Takenaka et al. | Oct 2009 | A1 |
20090256702 | Robertson | Oct 2009 | A1 |
20090264714 | Chou | Oct 2009 | A1 |
20090264964 | Abrahamson | Oct 2009 | A1 |
20090265186 | Tarassenko et al. | Oct 2009 | A1 |
20090273467 | Elixmann | Nov 2009 | A1 |
20090281539 | Selig | Nov 2009 | A1 |
20090295548 | Ronkka | Dec 2009 | A1 |
20090296677 | Mahany | Dec 2009 | A1 |
20090303920 | Mahany | Dec 2009 | A1 |
20090306633 | Trovato et al. | Dec 2009 | A1 |
20090312619 | Say et al. | Dec 2009 | A1 |
20090318761 | Rabinovitz | Dec 2009 | A1 |
20090318779 | Tran | Dec 2009 | A1 |
20090318783 | Rohde | Dec 2009 | A1 |
20090318793 | Datta | Dec 2009 | A1 |
20100010330 | Rankers | Jan 2010 | A1 |
20100049006 | Magar | Feb 2010 | A1 |
20100049012 | Dijksman et al. | Feb 2010 | A1 |
20100049069 | Tarassenko et al. | Feb 2010 | A1 |
20100056878 | Partin | Mar 2010 | A1 |
20100056891 | Say et al. | Mar 2010 | A1 |
20100056939 | Tarassenko et al. | Mar 2010 | A1 |
20100057041 | Hayter | Mar 2010 | A1 |
20100062709 | Kato | Mar 2010 | A1 |
20100063438 | Bengtsson | Mar 2010 | A1 |
20100063841 | D'Ambrosia | Mar 2010 | A1 |
20100069002 | Rong | Mar 2010 | A1 |
20100069717 | Hafezi et al. | Mar 2010 | A1 |
20100081894 | Zdeblick et al. | Apr 2010 | A1 |
20100099967 | Say et al. | Apr 2010 | A1 |
20100099968 | Say et al. | Apr 2010 | A1 |
20100099969 | Say et al. | Apr 2010 | A1 |
20100100077 | Rush | Apr 2010 | A1 |
20100100078 | Say et al. | Apr 2010 | A1 |
20100106001 | Say et al. | Apr 2010 | A1 |
20100118853 | Godfrey | May 2010 | A1 |
20100139672 | Kroll et al. | Jun 2010 | A1 |
20100168659 | Say et al. | Jul 2010 | A1 |
20100179398 | Say et al. | Jul 2010 | A1 |
20100185055 | Robertson | Jul 2010 | A1 |
20100191073 | Tarassenko et al. | Jul 2010 | A1 |
20100210299 | Gorbachov | Aug 2010 | A1 |
20100222652 | Cho | Sep 2010 | A1 |
20100228113 | Solosko | Sep 2010 | A1 |
20100234706 | Gilland | Sep 2010 | A1 |
20100234715 | Shin | Sep 2010 | A1 |
20100234914 | Shen | Sep 2010 | A1 |
20100239616 | Hafezi et al. | Sep 2010 | A1 |
20100245091 | Singh | Sep 2010 | A1 |
20100249881 | Corndorf | Sep 2010 | A1 |
20100256461 | Mohamedali | Oct 2010 | A1 |
20100259543 | Tarassenko et al. | Oct 2010 | A1 |
20100268048 | Say et al. | Oct 2010 | A1 |
20100268049 | Say et al. | Oct 2010 | A1 |
20100268050 | Say et al. | Oct 2010 | A1 |
20100274111 | Say et al. | Oct 2010 | A1 |
20100280345 | Say et al. | Nov 2010 | A1 |
20100280346 | Say et al. | Nov 2010 | A1 |
20100295694 | Kauffman et al. | Nov 2010 | A1 |
20100298668 | Hafezi et al. | Nov 2010 | A1 |
20100298730 | Tarassenko et al. | Nov 2010 | A1 |
20100312188 | Robertson et al. | Dec 2010 | A1 |
20100312580 | Tarassenko et al. | Dec 2010 | A1 |
20110009715 | O'Reilly et al. | Jan 2011 | A1 |
20110054265 | Hafezi et al. | Mar 2011 | A1 |
20110065983 | Hafezi et al. | Mar 2011 | A1 |
20110105864 | Robertson et al. | May 2011 | A1 |
Number | Date | Country |
---|---|---|
0344939 | Dec 1989 | EP |
1246356 | Oct 2002 | EP |
1534054 | May 2005 | EP |
1702553 | Sep 2006 | EP |
1789128 | May 2007 | EP |
2143369 | Jan 2010 | EP |
61072712 | Apr 1986 | JP |
05-228128 | Sep 1993 | JP |
2000-506410 | May 2000 | JP |
2002263185 | Sep 2002 | JP |
2005073886 | Mar 2005 | JP |
2005-304880 | Apr 2005 | JP |
2006006377 | Jan 2006 | JP |
2006509574 | Mar 2006 | JP |
2007-313340 | Dec 2007 | JP |
2006077523 | Jul 2006 | KR |
8802237 | Apr 1988 | WO |
WO8802237 | Apr 1988 | WO |
WO9308734 | May 1993 | WO |
WO9319667 | Oct 1993 | WO |
WO9739963 | Oct 1997 | WO |
WO9843537 | Oct 1998 | WO |
WO9959465 | Nov 1999 | WO |
WO0033246 | Jun 2000 | WO |
WO0100085 | Jan 2001 | WO |
0147466 | Jul 2001 | WO |
WO0174011 | Oct 2001 | WO |
WO0180731 | Nov 2001 | WO |
WO0245489 | Jun 2002 | WO |
WO02058330 | Jul 2002 | WO |
WO02062276 | Aug 2002 | WO |
WO02087681 | Nov 2002 | WO |
WO03050643 | Jun 2003 | WO |
WO2004014225 | Feb 2004 | WO |
WO2004039256 | May 2004 | WO |
WO2004066834 | Aug 2004 | WO |
WO2004066903 | Aug 2004 | WO |
WO2004068881 | Aug 2004 | WO |
WO2004109316 | Dec 2004 | WO |
WO2005011237 | Feb 2005 | WO |
2005020023 | Mar 2005 | WO |
WO2005024687 | Mar 2005 | WO |
WO2005047837 | May 2005 | WO |
WO2005051166 | Jun 2005 | WO |
WO2005110238 | Nov 2005 | WO |
WO2006027586 | Mar 2006 | WO |
2006055892 | May 2006 | WO |
2006055956 | May 2006 | WO |
WO2006075016 | Jul 2006 | WO |
WO2006100620 | Sep 2006 | WO |
2006104843 | Oct 2006 | WO |
2006116718 | Nov 2006 | WO |
2006127355 | Nov 2006 | WO |
2007001724 | Jan 2007 | WO |
2007001742 | Jan 2007 | WO |
2007013952 | Feb 2007 | WO |
2007014084 | Feb 2007 | WO |
2007021496 | Feb 2007 | WO |
WO2007014527 | Feb 2007 | WO |
2007027660 | Mar 2007 | WO |
2007028035 | Mar 2007 | WO |
WO2007028035 | Mar 2007 | WO |
2007036741 | Apr 2007 | WO |
2007036746 | Apr 2007 | WO |
WO2007036687 | Apr 2007 | WO |
WO2007036741 | Apr 2007 | WO |
WO2007036746 | Apr 2007 | WO |
WO2007040878 | Apr 2007 | WO |
WO2007067054 | Jun 2007 | WO |
WO2007071180 | Jun 2007 | WO |
WO2007096810 | Aug 2007 | WO |
WO2007101141 | Sep 2007 | WO |
WO2007120946 | Oct 2007 | WO |
2007130491 | Nov 2007 | WO |
WO2007127316 | Nov 2007 | WO |
WO2007127879 | Nov 2007 | WO |
WO2007127945 | Nov 2007 | WO |
WO2007128165 | Nov 2007 | WO |
2007149546 | Dec 2007 | WO |
WO2007143535 | Dec 2007 | WO |
2008008281 | Jan 2008 | WO |
WO2008030482 | Mar 2008 | WO |
2008052136 | May 2008 | WO |
2008063626 | May 2008 | WO |
2008066617 | Jun 2008 | WO |
WO2008076464 | Jun 2008 | WO |
WO2008089232 | Jul 2008 | WO |
WO2008091683 | Jul 2008 | WO |
2008095183 | Aug 2008 | WO |
2008101107 | Aug 2008 | WO |
WO2008097652 | Aug 2008 | WO |
2008112577 | Sep 2008 | WO |
2008112578 | Sep 2008 | WO |
2008120156 | Oct 2008 | WO |
WO2008133394 | Nov 2008 | WO |
WO2008134185 | Nov 2008 | WO |
2009001108 | Dec 2008 | WO |
WO2008150633 | Dec 2008 | WO |
WO2009001108 | Dec 2008 | WO |
WO2009006615 | Jan 2009 | WO |
WO2009029453 | Mar 2009 | WO |
WO2009036334 | Mar 2009 | WO |
WO2009051829 | Apr 2009 | WO |
WO2009051830 | Apr 2009 | WO |
WO2009063377 | May 2009 | WO |
WO2009081348 | Jul 2009 | WO |
WO2009111664 | Sep 2009 | WO |
WO2009146082 | Dec 2009 | WO |
WO2010000085 | Jan 2010 | WO |
WO2010009100 | Jan 2010 | WO |
WO2010011833 | Jan 2010 | WO |
2010019778 | Feb 2010 | WO |
2010057049 | May 2010 | WO |
WO2010080765 | Jul 2010 | WO |
WO2010080843 | Jul 2010 | WO |
WO2010107563 | Sep 2010 | WO |
WO2010135516 | Nov 2010 | WO |
WO2011068963 | Jun 2011 | WO |
WO2011133799 | Oct 2011 | WO |
WO2011159336 | Dec 2011 | WO |
WO2011159337 | Dec 2011 | WO |
WO2011159338 | Dec 2011 | WO |
WO2011159339 | Dec 2011 | WO |
Entry |
---|
Jimbo, H. et al in “Gastric-fluid-utilized microbattery for micro medical devices”, The Sixth International Workshop on Micro and Nanotechnology for Power Generation and Energy Conversion Applications, Nov. 29-Dec. 1, 2006, Berkeley, U.S.A., p. 97-10. |
Soper, S. A. et al in “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346. |
Li, P-Y, et al in “An electrochemical intraocular drug delivery device”, Sensors and Actuators A 143 (2008) p. 41-48. |
Tierney, M. J., et al in “Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules”, J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006. |
Coury, L. “Conductance Measurement Part 1: Theory”, Current Separations, 18:3 (1999), p. 91-96. |
Watson, S. J. et al in “Determination of the relationship between the pH and conductivity of gastric juice”, Physiol. Meas. 17 (1996) p. 21-27. |
Soper, S. A. et al in “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346. 2006. |
Heydari et al., “Analysis of the PLL jitter due to power/ground and substrate noise”; IEEE Transactions on Circuits and Systems (2004) 51(12): 2404-16. |
Philips Respironics (http/minimitter.com/products.cfm) Products, Noninvasive Technology to Help Your Studies Succeed. 510(k) Permanent Notification for Vital Sense. Apr. 22, 2004. |
Sanduleanu et al., “Octave tunable, highly linear, RC-ring oscillator with differential fine-coarse tuning, quadrature outputs and amplitude control for fiber optic transceivers” (2002) IEEE MTT-S International Microwave Symposium Digest 545-8. |
Tajalli et al., “Improving the power-delay performance in subthreshold source-coupled logic circuits” Integrated Circuit and System Design. Power and Timing Modeling, Optimization and Simulation, Springer Berlin Heidelberg (2008) 21-30. |
Yang et al., “Fast-switching frequency synthesizer with a discriminator-aided phase detector” IEEE Journal of Solid-State Circuits (2000) 35(10): 1445-52. |
“Smartlife awarded patent for knitted transducer” Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009). |
Description of ePatch Technology Platform for ECG and EMG, located it http://www.madebydelta.com/imported/images/DELTA—Web/documents/ME/ePatch—ECG—EMG.pdf, Dated Sep. 2, 2010. |
Bohidar et al., “Dielectric Behavior of Gelatin Solutions and Gels” Colloid Polym Sci (1998) 276:81-86. |
Dhar et al., “Electroless nickel plated contacts on porous silicon” Appl. Phys. Lett. 68 (10) pp. 1392-1393 (1996). |
Eldek A., “Design of double dipole antenna with enhanced usable bandwidth for wideband phased array applications” Progress in Electromagnetics Research PIER 59, 1-15 (2006). |
Fawaz et al., “Enhanced Telemetry System using CP-QPSK Band- Pass Modulation Technique Suitable for Smart Pill Medical Application” IFIP IEEE Dubai Conference (2008); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP—IEEE—Dubai—Conference.pdf. |
Ferguson et al., “Dialectric Constant Studies III Aqueous Gelatin Solutions” J. Chem. Phys. 2, 94 (1934) p. 94-98. |
Furse C. M., “Dipole Antennas” J. Webster (ed). Wiley Encyclopedia of Electrical and Electronics Engineering (1999) p. 575-581. |
Given Imaging, “Agile Patency Brochure” (2006) http://www.inclino.no/documents/AgilePatencyBrochure—Global—GMB-0118-01.pdf; 4pp. |
ISFET—Ion Sensitive Field-Effect Transistor; Microsens S.A. pdf document. First in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345; 4pp. |
INTROMEDIC, MicroCam Innovative Capsule Endoscope Pamphlet. (2006) 8 pp (http://www.intromedic.com/en/product/productinfo.asp). |
Kamada K., “Electrophoretic deposition assisted by soluble anode” Materials Letters 57 (2003) 2348-2351. |
NPL—AntennaBasics.pdf, Radio Antennae, http://www.erikdeman.de/html/sail018h.htm; (2008) 3pp. |
O'Brien et al., “The Production and Characterization of Chemically Reactive Porous Coatings of Zirconium Via Unbalanced Magnetron Sputtering” Surface and Coatings Technology (1996) 86-87; 200-206. |
Roulstone, et al., “Studies on Polymer Latex Films: I. A study of latex film morphology” Polymer International 24 (1991) pp. 87-94. |
Shin et al., “A Simple Route to Metal Nanodots and Nanoporous Metal Films”; Nano Letters, vol. 2, No. 9 (2002) pp. 933-936. |
Shrivas et al., “A New Platform for Bioelectronics-Electronic Pill”, Cummins College, (2010).; http://www.cumminscollege.org/downloads/electronics—and—telecommunication/Newsletters/Current%20Newsletters.pdf; First cited in third party client search conducted by Patent Eagle Search May 18, 2010. |
“The SmartPill Wireless Motility Capsule” Smartpill, The Measure of GI Health; (2010) http://www.smartpillcorp.com/index.cfm?pagepath=Products/The—SmartPill—Capsule&id=17814. |
Soper, S.A. et al. “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346 (2007). |
U.S. Appl. No. 12/238,345 filed Sep. 25, 2008, Hooman et al., Non-Final Office Action mailed Jun. 13, 2011 22pp. |
Walkey, “MOSFET Structure and Processing”; 97.398* Physical Electronics Lecture 20; First in Office Action dated Jun. 13, 2011 for U.S. Appl. No. 12/238,345; 24 pp. |
Wongmanerod et al., “Determination of pore size distribution and surface area of thin porous silicon layers by spectroscopic ellipsometry” Applied Surface Science 172 (2001) 117-125. |
ISFET—Ion Sensitive Field-Effect Transistor; Microsens S.A. pdf document. pp. 1-4. |
Walkey, “MOSFET Struture and Processing”; 97.398* Physical Electronics Lecture 20; pp. 1-24. |
MacKay et al., Radio telemetering from within the body: Inside information is revealed by tiny transmitters that can be swallowed or implanted in man or animal. Science 1961;134(3486):1196-1202. |
MacKay et al,. Endoradiosonde. Nature 1957;179(4572):1239-40, 179. |
Zworkin, A ‘radio pill.’ Nature 1957;179:898. |
Yao et al., Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues. Proceedings of the 28th IEEE, EMBC Annual International Conference (Aug. 30-Sep. 3, 2006); New York, USA. |
McKenzie et al., Validation of a new telemetric core temperature monitor. J. Therm. Biol. 2004;29(7-8):605-11. |
Tatbul et al., Confidence-based data management for personal area sensor networks. ACM International Conference Proceeding Series 2004;72. |
Zimmerman, Personal Area Networks: Near-field intrabody communication. IBM Systems Journal 1996;35 (3-4):609-17. |
Mini Mitter Co, Inc. 510(k) Premarket Notification Mini-Logger for Diagnostic Spirometer. Sep. 21, 1999. |
Mini Mitter Co, Inc. 510(k) Premarket Notification for VitalSense. Apr. 22, 2004. |
Mini Mitter Co, Inc. Actiheart. Traditional 510(k) Summary. Sep. 27, 2005. |
Mini Mitter Co, Inc. VitalSense- Wireless Vital Signs Monitoring. Temperatures.com Mar. 31, 2009. |
Mini Mitter Co, Inc. Noninvasive technology to help your studies succeed. Mini Mitter.com Mar. 31, 2009. |
Barrie, Heidelberg pH capsule gastric analysis. Textbook of Natural Medicine, 1992, Pizzomo, Murray & Barrie. |
Carlson et al., Evaluation of a non-invasive respiratory monitoring system for sleeping subjects. Physiological Measurement 1999;20(1):53. |
Mojaverian et al., Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition. Gastroenterology 1985;89(2):392-7. |
Xiaoming et al., A telemedicine system for wireless home healthcare based on bluetooth and the internet. Telemedicine Journal and e-health 2004;10(S2):S110-6. |
Arshak et al., A Review and Adaptation of Methods of Object Tracking to Telemetry Capsules IC-Med (2007) vol. 1, No. 1, Issue 1, pp. 35 of 46. |
“ASGE Technology Status Evaluation Report: wireless capsule endoscopy” American Soc. For Gastrointestinal Endoscopy (2006) vol. 63, No. 4; 7 pp. |
Aydin et al., “Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems” Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003); abstract. |
Brock, “Smart Medicine: The Application of Auto-ID Technology to Healthcare” Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf. |
Delvaux et al., “Capsule endoscopy: Technique and indications” Clinical Gastoenterology (2008) vol. 22, Issue 5, pp. 813-837. |
Fawaz et al., “Enhanced Telemetry System using CP-QPSK Band- Pass Modulation Technique Suitable for Smart Pill Medical Application” IFIP IEEE Dubai Conference (N.D.); http://www.asic.fh-offenburg.de/downloads/ePille/IFIP—IEEE—Dubai—Conference.pdf. |
Given Imaging, “Agile Patency Brochure” http://www.inclino.no/documents/AgilePatencyBrochure—Global—GMB-0118-01.pdf;(N.D.) 4pp. |
Gonzalez-Guillaumin et al., “Ingestible capsule for impedance and pH monitoring in the esophagus” IEEE Trans Biomed Eng. (2007) 54(12: 2231-6; abstract. |
Greene, “Edible RFID microchip monitor can tell if you take your medicine” Bloomberg Businessweek (2010) 2 pp.; http://www.businessweek.com/idg/2010-03-31/edible-rfid-microchip-monitor-can-tell-if-you-take-your-medicine.html. |
Melanson, “Walkers swallow RFID pills for science” Engadget (2008); http://www.engadget.com/2008/07/29/walkers-swallow-rfid-pills-for-science/. |
“New ‘smart pill’ to track adherence” E-Health-Insider (2010) http://www.e-health-insider.com/news/5910/new—‘smart—pill’—monitors—medicines. |
“RFID “pill” monitors marchers” RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/. |
“SensiVida minimally invasive clinical systems” Investor Presentation (Oct. 2009) 28pp; http://www.sensividamedtech.com/SensiVidaGeneralOctober09.pdf. |
Shrivas et al., “A New Platform for Bioelectronics-Electronic Pill”, Cummins College, N.D.; http://www.cumminscollege.org/downloads/electronics—and—telecommunication/Newsletters/Current%20Newsletters.pdf. |
“The SmartPill Wireless Motility Capsule” SMARTPILL, The Measure of GI Health; http://www.smartpillcorp.com/index.cfm?pagepath=Products/The—SmartPill—Capsule&id=17814. |
Solanas et al., “RFID Technology for the Health Care Sector” Recent Patents on Electrical Engineering (2008) 1, 22-31. |
Swedberg, “University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials” RFID Journal (Apr. 27, 2010); http://www.rfidjournal.com/article/view/7560/1. |
University of Florida News “Rx for health: Engineers design pill that signals it has been swallowed” (2010) 2pp.; http://news.ufl.edu/2010/03/31/antenna-pill-2/. |
Gilson, D.R. “Molecular dynamics simulation of dipole interactions”, Department of Physics, Hull University, Dec. 2002, p. 1-43. |
Li, P-Y, et al. “An electrochemical intraocular drug delivery device”, Sensors and Actuators A 143 (2008) p. 41-48. |
NPL—AntennaBasics.pdf, p. 1-3, Date: Jan. 11, 2008. |
Santini, J.T. et al, “Microchips as controlled drug delivery-devices”, Agnew. Chem. Int. Ed. 2000, vol. 39, p. 2396-2407. |
Shawgo, R.S. et al. “BioMEMS from drug delivery”, Current Opinion in Solid State and Material Science 6 (2002), p. 329-334. |
Soper, S.A. et al. “Bio-Mems Technologies and Applications”, Chapter 12, “MEMS for Drug Delivery”, p. 325-346, Date: 2006. |
Tierney, M.J. et al “Electroreleasing Composite Membranes for Delivery of Insulin and other Biomacromolecules”, J. Electrochem. Soc., vol. 137, No. 6, Jun. 1990, p. 2005-2006. |
Jung, S. “Dissolvable ‘Transient Electronics’ Will Be Good for Your Body and the Environment” MedGadget; Oct. 1, 2012; Onlne website: http://medgadget.com/2012/10/dissolvable-transient-electronics-will-be-good-for-your-body-and-the-environment.html; downloaded Oct. 24, 2012; 4 pp. |
Trutag, Technologies, Inc., Spectral Microtags for Authentication and Anti-Counterfeiting; “Product Authentication and Brand Protection Solutions”; http://www.trutags.com/; downloaded Feb. 12, 2013; 1 pp. |
Number | Date | Country | |
---|---|---|---|
20100298668 A1 | Nov 2010 | US |
Number | Date | Country | |
---|---|---|---|
61088355 | Aug 2008 | US |